Quoin Pharmaceuticals Ltd. (QNRX)
6.97
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 14:19
Quoin Pharmaceuticals Price to Book Value : 3.560 for Sept. 10, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 3.560 |
| September 08, 2026 | 3.652 |
| September 04, 2026 | 3.708 |
| September 03, 2026 | 4.019 |
| September 02, 2026 | 3.442 |
| September 01, 2026 | 3.325 |
| August 31, 2026 | 3.177 |
| August 28, 2026 | 3.126 |
| August 27, 2026 | 2.633 |
| August 26, 2026 | 2.646 |
| August 25, 2026 | 2.589 |
| August 24, 2026 | 2.768 |
| August 21, 2026 | 2.845 |
| August 20, 2026 | 2.548 |
| August 19, 2026 | 2.410 |
| August 18, 2026 | 2.538 |
| August 17, 2026 | 2.651 |
| August 14, 2026 | 2.600 |
| August 13, 2026 | 3.090 |
| August 12, 2026 | 3.008 |
| August 11, 2026 | 2.732 |
| August 10, 2026 | 2.737 |
| August 07, 2026 | 2.446 |
| August 06, 2026 | 2.334 |
| August 05, 2026 | 2.232 |
| Date | Value |
|---|---|
| August 04, 2026 | 2.222 |
| August 03, 2026 | 2.273 |
| July 31, 2026 | 2.273 |
| July 30, 2026 | 2.247 |
| July 29, 2026 | 2.183 |
| July 28, 2026 | 2.145 |
| July 27, 2026 | 2.191 |
| July 24, 2026 | 2.186 |
| July 23, 2026 | 2.232 |
| July 22, 2026 | 2.234 |
| July 21, 2026 | 2.176 |
| July 20, 2026 | 2.150 |
| July 17, 2026 | 2.165 |
| July 16, 2026 | 2.124 |
| July 15, 2026 | 2.150 |
| July 14, 2026 | 2.222 |
| July 13, 2026 | 2.160 |
| July 10, 2026 | 2.273 |
| July 09, 2026 | 2.385 |
| July 08, 2026 | 2.410 |
| July 07, 2026 | 2.451 |
| July 06, 2026 | 2.349 |
| July 02, 2026 | 2.339 |
| July 01, 2026 | 2.405 |
| June 30, 2026 | 2.472 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.620 |
| Alnylam Pharmaceuticals, Inc. | 24.49 |
| Anika Therapeutics, Inc. | 2.029 |
| Savara, Inc. | 7.563 |
| Vericel Corp. | 5.216 |
Price to Book Value Related Metrics
| Price | 6.97 |
| Earnings Yield | -214.1% |
| Market Cap | 14.00M |